New CAR T-Cell therapy extends remission in heavily relapsed multiple myeloma patients

A new type of CAR T-cell therapy more than triples the expected length of remission for multiple myeloma patients who have relapsed several times, according to an international clinical trial. View original article here Source

Related Posts